Peptide Encyclopedia / HMG
EncyclopediaHMG is a purified gonadotropin of FSH and LH activity extracted from postmenopausal urine. It holds FDA approval as a prescription fertility medicine for ovulation induction and for spermatogenesis in hypogonadotropic men, given under specialist monitoring. Below you'll find reported dosing, reconstitution, safety, and legal status. Educational only, not medical advice.
| Category | Sexual Health |
| Half-life | 30-40 hours |
| Regulatory status | FDA-approved prescription gonadotropin (e. |
Purified preparation of FSH and LH activity (extracted from postmenopausal urine). FSH stimulates follicular/spermatogenic development and LH activity supports steroidogenesis and ovulation.
FSH component terminal half-life roughly 30-40 hours. Commonly reported use/dosing: FDA-approved for ovulation induction/controlled ovarian stimulation in assisted reproduction, and for spermatogenesis induction in men with hypogonadotropic hypogonadism. Reported as daily IM/SC injection during stimulation cycles under fertility-specialist supervision.
FDA-approved prescription gonadotropin (e.g., Menopur; historically Repronex/Pergonal). Prescription-only and used in monitored fertility settings.
Ovarian hyperstimulation syndrome, multiple gestation, thromboembolic events, abdominal/pelvic discomfort, injection-site reactions; requires monitoring (ultrasound, estradiol).
Mature, long-established for approved fertility indications.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. HMG may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.